A Study to Evaluate the Efficacy and Safety of CT041 After Adjuvant Chemotherapy for Pancreatic Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Xianjun Yu, Ph.D
Fudan University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Beijing Cancer Hospital
Beijing, Beijing Municipality, China
Recruiting - Henan Cancer Hospital
Zhengzhou, Henan, China
Recruiting - Union Hospital, Tongji Medical College, Hua Zhong University of Science and Technology
Wuhan, Hubei, China
Recruiting - Hunan Provincial People'S Hospital
Changsha, Hunan, China
Recruiting - Fudan University Shanghai Cancer Hospital
Shanghai, Shanghai Municipality, China
Recruiting - Ruijin Hospital, Affiliated To Shanghai Jiaotong University, School of Medicine
Shanghai, Shanghai Municipality, China
Recruiting - the First Affiliated Hospital of Xi'An Jiaotong University
Xian, Shanxi, China
Recruiting - Zhejiang Provincial People'S Hospital
Hangzhou, Zhejiang, China
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 11 Jul 2023
- Primary completion
- 31 Dec 2026
- Completion
- 31 Dec 2026
- Last update posted
- 28 May 2024
- Registered enrollment
- 20
- Registry id
- NCT05911217
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.